SMS Pharmaceuticals Limited — Important, 17-06-2025: General Updates

SMS Pharmaceuticals has announced a board meeting to discuss the financial results for the quarter and half-year. The company received trading approval for 40 lakh equity shares allotted to promoters at a Rs. 126 premium per share upon warrant conversion. These shares are now listed and admitted for trading on BSE and NSE, subject to a lock-in period until March 2027. This capital infusion strengthens the promoter shareholding base without immediate financial impact reported.